Top Doctor: The hidden dangers in your daily multivitamin | Dr David Seres

Main Ideas

1. Vitamins can be essential—but more is not automatically better

• Vitamins have prevented or treated serious deficiency diseases, including scurvy, rickets, and iodine-deficiency disorders. Those successes helped create expectations that supplements could also extend health and longevity for people without deficiencies.
• Dr. David Seres’s central warning is that the idea “if some is good, more must be better” is false. High doses can cause harm; he says very large doses of vitamin D can be toxic and potentially deadly.
• Supplements may be appropriate when a deficiency or specific risk has been identified and a clinician recommends them. Seres argues that routine use by generally healthy people has not been shown to provide reliable benefit.

2. Supplements face less pre-market scrutiny than medicines in the US

• Seres describes the US dietary-supplement framework as having been substantially loosened by the Dietary Supplement Health and Education Act, which he dates to 1995. He says a campaign featuring Mel Gibson helped build public support for the legislation.
• Under the system he describes, supplements generally do not need to demonstrate effectiveness or undergo the same pre-market safety testing as drugs. Companies can make certain “structure/function” claims—for example, that a product “supports heart health”—without proving that it prevents or treats disease.
• Drug companies, by contrast, must test medicines in clinical trials and obtain FDA approval for them to be sold as drugs.
• Seres says there is no comparable requirement in the US for a supplement company to submit a health claim for approval before marketing a product. Legal action is more likely when companies make disease-treatment claims or engage in fraudulent advertising.

3. Marketing can make weak or indirect evidence sound conclusive

Seres describes several ways supplement claims can overstate what research shows:

• Evidence from cells or laboratory settings: A substance may affect a cell in a dish, but that does not establish that taking it benefits a person. Biology involves many interacting processes, so effects observed at one step do not reliably predict a health outcome.
• Observational associations: Finding that people with a condition have lower levels of a nutrient does not show that low levels caused the condition. The illness itself may have lowered the nutrient level.
• Selective statistical findings: Repeatedly testing subgroups can turn up results that look significant by chance. Seres recounts a memory-supplement case in which the overall trial outcome was negative, but selected subgroup analyses were used to suggest a benefit.
• Ingredient research versus product evidence: Evidence that individual ingredients have been studied—especially in cells or other indirect settings—does not establish that a particular finished supplement works.

4. Randomized trials are important for testing cause and effect

• Seres distinguishes observational research, which can identify associations, from randomized controlled trials (RCTs), which compare people assigned to a treatment with people assigned to a placebo or standard care.
• Large trials are needed to reduce the influence of differences between people, such as genetics, health conditions, and living circumstances.
• He says RCTs of supplements have often failed to show benefit for the general healthy population. He also notes that large, long-term trials are expensive and difficult to conduct.

5. Examples discussed in the interview

• Vitamin E and selenium: Seres describes a large, long-term study of roughly 30,000 men in which supplementation was associated with an approximately 18% higher rate of prostate cancer. He uses it to illustrate why low nutrient levels observed in people with cancer do not necessarily mean supplementation will prevent cancer.
• Vitamin C: He says trials have generally shown no clear benefit for healthy people without a deficiency. He mentions a possible exception: some studies found fewer colds among people undertaking intense endurance exercise, such as marathon running or intense skiing. He says any use in that context would involve lower doses than commonly promoted.
• Vitamin D: Seres questions the evidence behind some widely used “insufficient” thresholds and says trials have not shown much benefit from supplementation for the general population. He notes possible limited findings, such as a slight reduction in falls in some older adults, but does not consider the evidence strong enough for routine use. He warns that high doses can be toxic and advises discussing low levels or risk factors with a doctor.
• Critically ill patients and COVID-19: Seres says observational links between vitamin D levels and outcomes in critically ill patients led to interest in supplementation, but randomized trials did not show benefit. He also says randomized trials of high-dose vitamin C in critically ill patients did not show enough benefit to outweigh potential concerns.
• Multivitamins and older age: He acknowledges suggestive evidence linking multivitamin use with lower rates of some outcomes, including dementia, but considers it too weak to justify routine supplementation simply because someone is older.
• Probiotics and prebiotics: Seres says many commercial probiotics contain organisms that are not usual long-term residents of the gut and that evidence for health benefits is limited. Prebiotics are typically fermentable fibers; he says proposed benefits are not fully established and that fermentation can cause gas and bloating. “Synbiotics” combine a prebiotic and a probiotic.

6. Science and public trust

• Seres says scientific guidance can change as evidence improves, but scientists have not always communicated the strength and limitations of the evidence well.
• He acknowledges that earlier dietary advice—such as recommending low-fat diets—was bad advice in his view and may have made weight management harder for some people.
• He argues that experts should explain why recommendations change and be clearer about uncertainty, rather than expecting the public to trust advice without context.

7. Practical guidance offered

• Do not assume supplements are harmless or that higher doses are better.
• For generally healthy people, do not take supplements routinely unless a deficiency or specific risk has been identified and a doctor recommends them.
• Prioritize diet: When affordable and accessible, choose foods that are less processed and closer to their original form, and move toward a more plant-forward diet. Seres does not argue that everyone must eliminate animal products.
• Recognize uncertainty: He describes evidence supporting diet recommendations as suggestive rather than definitive, since long-term randomized trials of whole diets are difficult to conduct.
• Take individualized medical advice seriously: The conversation distinguishes routine supplement use from treatment of a diagnosed deficiency. The host, for example, says they take B12 after developing a deficiency.

Speakers and Sources Featured

Speakers

• Dr. David Seres — Director of Medical Nutrition and professor at Columbia University’s Institute of Human Nutrition; physician nutrition specialist.
• ZOE podcast host/interviewer — The host’s name is not given in the subtitles.

Sources and studies mentioned

• The Dietary Supplement Health and Education Act (DSHEA) and the FDA, in discussion of US supplement regulation.
• Mel Gibson’s supplement-law advertising campaign, described by Seres as helping promote the legislation.
• A large trial of vitamin E and selenium in men, referred to in the subtitles as the “Ohio Men’s Study.”
• PubMed, mentioned as a database for finding research articles.
• Studies and randomized trials involving vitamin C, vitamin D, probiotics, and prebiotics, including research in critically ill patients and studies relating vitamin D to COVID-19 outcomes.
• A memory-supplement court case described by Seres; the company and product are not named in the subtitles.